Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis

Clinical trial NCT01450488 · COMPLETED

Trial details

NCT number: NCT01450488
Sponsor: AB Science
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2005-06-01
Primary completion: 2007-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.